Thrombopoietin Level Predicts Response to Treatment with Romiplostim in Chemotherapy-Induced Thrombocytopenia

被引：0
|
作者：
Song, Andrew B. [1 ,2 ]
Goodarzi, Katayoon [1 ,3 ]
Leaf, Rebecca Karp [1 ,3 ]
Kuter, David J. [1 ,4 ]
Al-Samkari, Hanny [1 ,5 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02114 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Hematol Div, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-145931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
584
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Chemotherapy-induced thrombocytopenia: modern diagnosis and treatment
    Song, Andrew B.
    Al-Samkari, Hanny
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [42] Hetrombopag plus recombinant human thrombopoietin for chemotherapy-induced thrombocytopenia in patients with solid tumors
    Xia, Xiaohui
    Zhou, Haiting
    Zhang, Hao
    Deng, Wanjun
    Li, Rui
    Huang, Qiao
    Wang, Yuehua
    Xiong, Huihua
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (07)
  • [43] Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation
    Fu, Haixia
    Lv, Meng
    Liu, Huixin
    Sun, Yuqian
    Zhang, Yuanyuan
    Mo, Xiaodong
    Han, Tingting
    Wang, Fengrong
    Yan, Chenhua
    Wang, Yu
    Kong, Jun
    Han, Wei
    Chen, Huan
    Chen, Yao
    Chen, Yuhong
    Xu, Lanping
    Liu, Kaiyan
    Huang, Xiaojun
    Zhang, Xiaohui
    BONE MARROW TRANSPLANTATION, 2023, 58 (12) : 1368 - 1376
  • [44] Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation
    Haixia Fu
    Meng Lv
    Huixin Liu
    Yuqian Sun
    Yuanyuan Zhang
    Xiaodong Mo
    Tingting Han
    Fengrong Wang
    Chenhua Yan
    Yu Wang
    Jun Kong
    Wei Han
    Huan Chen
    Yao Chen
    Yuhong Chen
    Lanping Xu
    Kaiyan Liu
    Xiaojun Huang
    Xiaohui Zhang
    Bone Marrow Transplantation, 2023, 58 : 1368 - 1376
  • [45] Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC)
    Natale, R.
    Charu, V.
    Schuette, W.
    Albert, I.
    Tehenes, S.
    McCoy, J.
    Berger, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 574 - 574
  • [46] Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia
    K Shinjo
    A Takeshita
    S Nakamura
    K Naitoh
    M Yanagi
    T Tobita
    K Ohnishi
    R Ohno
    Leukemia, 1998, 12 : 295 - 300
  • [47] Impact of Romiplostim on Overall Survival in Chemotherapy Induced Thrombocytopenia
    Wilkins, Cy R.
    Zwicker, Jeffrey I.
    Derkach, Andriy
    Burge, Miranda
    BLOOD, 2023, 142
  • [48] Romiplostim for chemotherapy induced thrombocytopenia in solid tumors: A metaanalysis
    Sainatham, Chiranjeevi
    Singh, Sahib
    Agrawal, Shubham
    Babu, Aravind Dilli
    Vinnakota, Sailaja
    Tallapalli, Jayanth Reddy
    Jindal, Vishal
    Kumar, Pallavi P.
    Lutfi, Forat
    Patell, Rushad
    Paul, Sonal
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia
    Shinjo, K
    Takeshita, A
    Nakamura, S
    Naitoh, K
    Yanagi, M
    Tobita, T
    Ohnishi, K
    Ohno, R
    LEUKEMIA, 1998, 12 (03) : 295 - 300
  • [50] Romiplostim for Treatment and Prevention of Chemotherapy-Associated Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    Goodarzi, Katayoon
    Marshall, Ariela L.
    BLOOD, 2016, 128 (22)
12345